Morbidity, Mortality And Risk Factors of Mpox in HIV Negative High Risk

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05512949` - Trial to Evaluate the Immunogenicity of Dose Reduction Strategies of the MVA-BN Monkeypox Vaccine	Phase 2
Completed	`NCT05976100` - Study of the Safety, Tolerability, Pharmacokinetics of NIOCH-14 in Volunteers Aged 18-50 Years	Phase 1
Recruiting	`NCT05988203` - A Clinical Study Investigating the Safety and Immune Responses After Immunization With Investigational Monkeypox Vaccines	Phase 1
Terminated	`NCT05567939` - Clinical, Virological, Immunological, Psychosocial and Epidemiological Consequences of Human Monkeypox Virus (ProMPX)
Active, not recruiting	`NCT05562323` - Characterization of Vaccine-induced Responses Against Monkeypox (MoVIHvax) An Observational Prospective Cohort Study
Recruiting	`NCT05534984` - Study of Tecovirimat for Human Monkeypox Virus	Phase 3
Not yet recruiting	`NCT05745987` - Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT	Phase 4
Not yet recruiting	`NCT05784038` - Observational, Prospective, Cohort Study of Mpox Infection in Brazil (NETPOX)
Recruiting	`NCT05879965` - Prospective Study for the FOLLOW-UP of Human Monkeypox Cases and Smallpox Vaccinees at Risk
Completed	`NCT03745131` - Cohort Study of Healthcare Workers Receiving Imvanex®
Recruiting	`NCT05559099` - Tecovirimat for Treatment of Monkeypox Virus	Phase 2
Completed	`NCT05846243` - Study on Immunogenicity, Reactogenicity and Safety of the VACΔ6 Vaccine in Volunteers Aged 18-60 Years	Phase 2/Phase 3
Not yet recruiting	`NCT05629299` - Pilot Study to Detect Monkey Pox Virus in Sperm: POXSPERM	N/A
Recruiting	`NCT05654883` - New York City Observational Study of Mpox Immunity
Completed	`NCT05762523` - Safety and Tolerability Study of the VAC∆6 Vaccine in Volunteers Aged 18-40 Years	Phase 1
Recruiting	`NCT05597735` - Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus Disease	Phase 3
Recruiting	`NCT05734508` - Assessment of Safety Profile of MVA-BN Vaccine in the PALM-007 Study in DRC	Phase 4
Active, not recruiting	`NCT05740982` - A Phase 2 Randomized Multisite Trial to Inform Public Health Strategies Involving the Use of MVA-BN Vaccine for Mpox	Phase 2
Recruiting	`NCT05947786` - Mpox Paediatric and Adolescent Clinical Study
Recruiting	`NCT06045923` - Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV

NCT number	NCT05965427
Study type	Observational
Source	NEAT ID Foundation
Contact	Debbie Roberts, PhD
Phone	07956761151
Email	debbie.roberts@rokcservices.com
Status	Recruiting
Phase
Start date	December 1, 2023
Completion date	December 2024

Morbidity, Mortality And Risk Factors of Mpox in HIV Negative High Risk Sexual Health Clinic Attenders and People Living With HIV — MASH 1

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms